NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire our relentless research and development in advancing treatments. Our grand passion is to change the cancer treatment paradigm and make a difference in patient lives every day.
View Top Employees from NewLink GeneticsWebsite | http://www.newlinkgenetics.com |
Ticker | NASDAQ:NLNK |
Employees | 33 (33 on RocketReach) |
Founded | 1999 |
Address | 2503 S Loop Dr, Ames, Iowa 50010, US |
Phone | (515) 598-2928 |
Technologies |
HTML,
Nginx,
Microsoft Outlook
+22 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Science and Engineering, Genetics, Health Care, Therapeutics |
Web Rank | 7 Million |
Keywords | Newlink Genetics, Nlnk News, Thomas Raffin |
Looking for a particular NewLink Genetics employee's phone or email?
Tatiana Seregina is the Vice President for Clinical and Regulatory Affairs of NewLink Genetics.
33 people are employed at NewLink Genetics.
NewLink Genetics is based in Ames, Iowa.